Cargando…

Can Gut Microbiota Be a Good Predictor for Parkinson’s Disease? A Machine Learning Approach

The involvement of the gut microbiota in Parkinson’s disease (PD), investigated in several studies, identified some common alterations of the microbial community, such as a decrease in Lachnospiraceae and an increase in Verrucomicrobiaceae families in PD patients. However, the results of other bacte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietrucci, Daniele, Teofani, Adelaide, Unida, Valeria, Cerroni, Rocco, Biocca, Silvia, Stefani, Alessandro, Desideri, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226159/ https://www.ncbi.nlm.nih.gov/pubmed/32325848 http://dx.doi.org/10.3390/brainsci10040242

Ejemplares similares

Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease
por: Cerroni, Rocco, et al.
Publicado: (2022)

Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders
por: Teofani, Adelaide, et al.
Publicado: (2022)

Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease
por: Lai, Silvia, et al.
Publicado: (2019)

Machine Learning Data Analysis Highlights the Role of Parasutterella and Alloprevotella in Autism Spectrum Disorders
por: Pietrucci, Daniele, et al.
Publicado: (2022)

In Silico and In Cell Analysis of Openable DNA Nanocages for miRNA Silencing
por: Raniolo, Sofia, et al.
Publicado: (2019)

Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells
por: Unida, Valeria, et al.
Publicado: (2022)

Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures
por: Raniolo, Sofia, et al.
Publicado: (2021)

AS1411 Aptamer Linked to DNA Nanostructures Diverts Its Traffic Inside Cancer Cells and Improves Its Therapeutic Efficacy
por: Vindigni, Giulia, et al.
Publicado: (2021)

Impact of Insulin Degludec/Liraglutide Fixed Combination on the Gut Microbiomes of Elderly Patients With Type 2 Diabetes: Results From A Subanalysis of A Small Non-Randomised Single Arm Study
por: Rizza, Stefano, et al.
Publicado: (2023)

Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease
por: Sisto, Renata, et al.
Publicado: (2020)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant
por: Falconi, Mattia, et al.
Publicado: (2007)

Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?
por: Stefani, Alessandro, et al.
Publicado: (2022)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG
por: Conti, Matteo, et al.
Publicado: (2022)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
por: Carpi, Matteo, et al.
Publicado: (2023)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
por: Conti, Matteo, et al.
Publicado: (2022)

Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis
por: Suppa, Antonio, et al.
Publicado: (2023)

Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease
por: Garasto, Elena, et al.
Publicado: (2023)

Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort
por: Bovenzi, Roberta, et al.
Publicado: (2023)

Gut microbiota: Implications in Parkinson's disease
por: Parashar, Arun, et al.
Publicado: (2017)

Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
por: Bovenzi, Roberta, et al.
Publicado: (2021)

Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study
por: Gnarra, Oriella, et al.
Publicado: (2023)

A Comparative Genomic Analysis Provides Novel Insights Into the Ecological Success of the Monophasic Salmonella Serovar 4,[5],12:i:-
por: Mastrorilli, Eleonora, et al.
Publicado: (2018)

Deciphering the Broad Antimicrobial Activity of Melaleuca alternifolia Tea Tree Oil by Combining Experimental and Computational Investigations
por: Iacovelli, Federico, et al.
Publicado: (2023)

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
por: Yang, Dongming, et al.
Publicado: (2019)

Gut, oral and nasal microbiota and Parkinson’s disease
por: Shen, Liang
Publicado: (2020)

Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
por: Yemula, Nehal, et al.
Publicado: (2021)

The Interplay between Medical Plants and Gut Microbiota in Cancer
por: Caserta, Santino, et al.
Publicado: (2023)

The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
por: Nandi, Deeptashree, et al.
Publicado: (2023)

Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
por: Kang, Yongbo, et al.
Publicado: (2021)

Functional Analysis and Molecular Dynamics Simulation of LOX-1 K167N Polymorphism Reveal Alteration of Receptor Activity
por: Biocca, Silvia, et al.
Publicado: (2009)

Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
por: Vascellari, Sarah, et al.
Publicado: (2020)

Corrigendum: The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
por: Yang, Dongming, et al.
Publicado: (2020)

Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease
por: Palacios, Natalia, et al.
Publicado: (2021)

2350: The role of gut microbiota in the susceptibility of Parkinson disease development
por: Koutzoumis, Dimitri, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_63b1630gos9ffc41lj1sq047bg